Kala Pharmaceuticals to Report Third Quarter 2020 Financial Results and Host Conference Call
The dial-in numbers to access the conference call are 866-300-4091 (domestic) or 703-736-7433 (international) using the conference ID 9199546. To access a live webcast and subsequent archived recording of the call, please visit the “Investors & Media” section on the Kala website at http://kalarx.com/.
About
Kala is a biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapies for diseases of the eye. Kala has applied its AMPPLIFY® mucus penetrating particle Drug Delivery Technology to a corticosteroid, loteprednol etabonate (LE), designed for ocular applications, resulting in the
View source version on businesswire.com: https://www.businesswire.com/news/home/20201029005165/en/
loraine.spreen@kalarx.com
857-277-4842
hannah.deresiewicz@sternir.com
212-362-1200
Source: